Event Details
Date: 25 November 2025
Location name:
Webinar
Location address:
@6.00pm - 7.15pm
Web: Register here
This session will explore how artificial intelligence (AI) is reshaping prostate cancer imaging from MRI diagnostics to treatment planning and what it means for your clinical practice.
Featured Speakers Include:
• David Bazaga, VP of Product, Quibim ‘The role of AI in improving patient outcomes in prostate MRI’
• Anthony Rix, CEO & Co-Founder, Lucida Medical ‘AI in the prostate cancer pathway: What are the real benefits?’
• Jana Schulte, Portfolio Director, NHS InSites Programme
